Objectives: Experimental studies have shown involvement of Wnt signalling in heart failure (HF). We hypothesized that secreted frizzled-related protein 3 (sFRP3), a modulator of Wnt signalling, is related to the progression of HF. Design: Circulating sFRP3 was measured in 153 HF patients and compared with 25 healthy controls. The association of sFRP3 with mortality was evaluated in 1202 patients (GISSI-HF trial). sFRP3 mRNA expression was assessed in failing human and murine left ventricles (LV), and cellular localization was determined after fractioning of myocardial tissue. In vitro studies were carried out in cardiac fibroblasts subjected to cyclic mechanical stretch. Results: (i) Heart failure patients had significantly raised serum sFR...
Heart failure is one of the most common cause of death in Germany. The current treatment options are...
Heart failure (HF) is a leading cause of morbidity and mortality across the world. Cardiac fibrosis ...
Background: Several beneficial effects have been demonstrated for secretogranin II (SgII) in non-car...
Objectives: Experimental studies have shown involvement of Wnt signalling in heart failure (HF). We ...
Experimental studies have shown involvement of Wnt signalling in heart failure (HF). We hypothesized...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
Background We have previously demonstrated an association between increased sFRP3 expression and adv...
Abstract Background Hemodynamic overload causes cardiac hypertrophy leading to heart failure. Wnt si...
On pathological stress, the heart reactivates several signaling pathways that traditionally were tho...
Background We have previously demonstrated an association between increased sFRP3 expression and adv...
Background: Beta-catenin has been implicated in cell-cell communication in a wide variety of develop...
Introduction: Arrhythmogenic cardiomyopathy (ACM) is a genetic disease of the myocardium, characteri...
Aims: Cardiac specificity provides an advantage in correlating heart failure (HF) biomarker plasma l...
Stem cell therapy has emerged as a promising tool for the treatment of a variety of diseases. Previo...
Heart failure is one of the most common cause of death in Germany. The current treatment options are...
Heart failure (HF) is a leading cause of morbidity and mortality across the world. Cardiac fibrosis ...
Background: Several beneficial effects have been demonstrated for secretogranin II (SgII) in non-car...
Objectives: Experimental studies have shown involvement of Wnt signalling in heart failure (HF). We ...
Experimental studies have shown involvement of Wnt signalling in heart failure (HF). We hypothesized...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
We have previously demonstrated an association between increased sFRP3 expression and adverse outcom...
Background We have previously demonstrated an association between increased sFRP3 expression and adv...
Abstract Background Hemodynamic overload causes cardiac hypertrophy leading to heart failure. Wnt si...
On pathological stress, the heart reactivates several signaling pathways that traditionally were tho...
Background We have previously demonstrated an association between increased sFRP3 expression and adv...
Background: Beta-catenin has been implicated in cell-cell communication in a wide variety of develop...
Introduction: Arrhythmogenic cardiomyopathy (ACM) is a genetic disease of the myocardium, characteri...
Aims: Cardiac specificity provides an advantage in correlating heart failure (HF) biomarker plasma l...
Stem cell therapy has emerged as a promising tool for the treatment of a variety of diseases. Previo...
Heart failure is one of the most common cause of death in Germany. The current treatment options are...
Heart failure (HF) is a leading cause of morbidity and mortality across the world. Cardiac fibrosis ...
Background: Several beneficial effects have been demonstrated for secretogranin II (SgII) in non-car...